APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cardiac AI-assisted Diagnosis

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Cardiac AI-assisted Diagnosis Market Analysis and Forecast 2026-2032

6 March 2026200 pages

Choose your research edition.

Industry ResearchCardiac AI-assisted Diagnosis Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Cardiac AI-assisted Diagnosis Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Cardiac AI-assisted Diagnosis Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cardiac AI-assisted Diagnosis Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Cardiac AI-assisted Diagnosis Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Cardiac AI-assisted Diagnosis market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Cardiac AI-assisted Diagnosis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Cardiac AI-assisted Diagnosis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Cardiac AI-assisted Diagnosis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Cardiac AI-assisted Diagnosis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Cardiac AI-assisted Diagnosis include Lepu Medical, G K Healthcare, Sense Time, United Imaging, Infervision, Shukun, FOSUN AITROX, NANO-X and MyCardium AI, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Cardiac AI-assisted Diagnosis, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Cardiac AI-assisted Diagnosis, also provides the revenue of main regions and countries. Of the upcoming market potential for Cardiac AI-assisted Diagnosis, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Cardiac AI-assisted Diagnosis revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Cardiac AI-assisted Diagnosis market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Cardiac AI-assisted Diagnosis revenue, projected growth trends, production technology, application and end-user industry.

Cardiac AI-assisted Diagnosis Segment by Company

Lepu Medical

G K Healthcare

Sense Time

United Imaging

Infervision

Shukun

FOSUN AITROX

NANO-X

MyCardium AI

VUNO

Caption Care

UltraSight

Ultromics

Cleerly

Elucid

DiA Imaging Analysis

Koninklijke Philips N.V

Fujifilm

Cardiac AI-assisted Diagnosis Segment by Type

Cloud-based

On-Primes

Cardiac AI-assisted Diagnosis Segment by Application

Hospital

Clinic

Imaging Center

Cardiac AI-assisted Diagnosis Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cardiac AI-assisted Diagnosis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cardiac AI-assisted Diagnosis and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cardiac AI-assisted Diagnosis.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Cardiac AI-assisted Diagnosis in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Cardiac AI-assisted Diagnosis company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cardiac AI-assisted Diagnosis revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Cardiac AI-assisted Diagnosis Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Cloud-based Major Player Table 3. On-Primes Major Player Table 4. Global Cardiac AI-assisted Diagnosis Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Player Table 6. Clinic Major Player Table 7. Imaging Center Major Player Table 8. Cardiac AI-assisted Diagnosis Industry Trends Table 9. Cardiac AI-assisted Diagnosis Industry Drivers Table 10. Cardiac AI-assisted Diagnosis Industry Opportunities and Challenges Table 11. Cardiac AI-assisted Diagnosis Industry Restraints Table 12. Global Cardiac AI-assisted Diagnosis Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Cardiac AI-assisted Diagnosis Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Cardiac AI-assisted Diagnosis Market Share by Region (2021-2026) Table 15. Global Cardiac AI-assisted Diagnosis Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Cardiac AI-assisted Diagnosis Market Share by Region (2027-2032) Table 17. Global Cardiac AI-assisted Diagnosis Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Cardiac AI-assisted Diagnosis Revenue Market Share by Players (2021-2026) Table 19. Global Cardiac AI-assisted Diagnosis Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Cardiac AI-assisted Diagnosis Key Players Headquarters & Area Served Table 21. Global Cardiac AI-assisted Diagnosis Players, Product Type & Application Table 22. Global Cardiac AI-assisted Diagnosis Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Cardiac AI-assisted Diagnosis by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Cardiac AI-assisted Diagnosis Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Cardiac AI-assisted Diagnosis Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Cardiac AI-assisted Diagnosis Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Cardiac AI-assisted Diagnosis Revenue Market Share by Type (2021-2026) Table 29. Global Cardiac AI-assisted Diagnosis Revenue Market Share by Type (2027-2032) Table 30. Global Cardiac AI-assisted Diagnosis Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Cardiac AI-assisted Diagnosis Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Cardiac AI-assisted Diagnosis Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Cardiac AI-assisted Diagnosis Revenue Market Share by Application (2021-2026) Table 34. Global Cardiac AI-assisted Diagnosis Revenue Market Share by Application (2027-2032) Table 35. Lepu Medical Company Information Table 36. Lepu Medical Business Overview Table 37. Lepu Medical Cardiac AI-assisted Diagnosis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Lepu Medical Cardiac AI-assisted Diagnosis Product Portfolio Table 39. Lepu Medical Recent Development Table 40. G K Healthcare Company Information Table 41. G K Healthcare Business Overview Table 42. G K Healthcare Cardiac AI-assisted Diagnosis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. G K Healthcare Cardiac AI-assisted Diagnosis Product Portfolio Table 44. G K Healthcare Recent Development Table 45. Sense Time Company Information Table 46. Sense Time Business Overview Table 47. Sense Time Cardiac AI-assisted Diagnosis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Sense Time Cardiac AI-assisted Diagnosis Product Portfolio Table 49. Sense Time Recent Development Table 50. United Imaging Company Information Table 51. United Imaging Business Overview Table 52. United Imaging Cardiac AI-assisted Diagnosis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. United Imaging Cardiac AI-assisted Diagnosis Product Portfolio Table 54. United Imaging Recent Development Table 55. Infervision Company Information Table 56. Infervision Business Overview Table 57. Infervision Cardiac AI-assisted Diagnosis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Infervision Cardiac AI-assisted Diagnosis Product Portfolio Table 59. Infervision Recent Development Table 60. Shukun Company Information Table 61. Shukun Business Overview Table 62. Shukun Cardiac AI-assisted Diagnosis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Shukun Cardiac AI-assisted Diagnosis Product Portfolio Table 64. Shukun Recent Development Table 65. FOSUN AITROX Company Information Table 66. FOSUN AITROX Business Overview Table 67. FOSUN AITROX Cardiac AI-assisted Diagnosis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. FOSUN AITROX Cardiac AI-assisted Diagnosis Product Portfolio Table 69. FOSUN AITROX Recent Development Table 70. NANO-X Company Information Table 71. NANO-X Business Overview Table 72. NANO-X Cardiac AI-assisted Diagnosis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. NANO-X Cardiac AI-assisted Diagnosis Product Portfolio Table 74. NANO-X Recent Development Table 75. MyCardium AI Company Information Table 76. MyCardium AI Business Overview Table 77. MyCardium AI Cardiac AI-assisted Diagnosis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. MyCardium AI Cardiac AI-assisted Diagnosis Product Portfolio Table 79. MyCardium AI Recent Development Table 80. VUNO Company Information Table 81. VUNO Business Overview Table 82. VUNO Cardiac AI-assisted Diagnosis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. VUNO Cardiac AI-assisted Diagnosis Product Portfolio Table 84. VUNO Recent Development Table 85. Caption Care Company Information Table 86. Caption Care Business Overview Table 87. Caption Care Cardiac AI-assisted Diagnosis Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. Caption Care Cardiac AI-assisted Diagnosis Product Portfolio Table 89. Caption Care Recent Development Table 90. UltraSight Company Information Table 91. UltraSight Business Overview Table 92. UltraSight Cardiac AI-assisted Diagnosis Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. UltraSight Cardiac AI-assisted Diagnosis Product Portfolio Table 94. UltraSight Recent Development Table 95. Ultromics Company Information Table 96. Ultromics Business Overview Table 97. Ultromics Cardiac AI-assisted Diagnosis Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Ultromics Cardiac AI-assisted Diagnosis Product Portfolio Table 99. Ultromics Recent Development Table 100. Cleerly Company Information Table 101. Cleerly Business Overview Table 102. Cleerly Cardiac AI-assisted Diagnosis Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Cleerly Cardiac AI-assisted Diagnosis Product Portfolio Table 104. Cleerly Recent Development Table 105. Elucid Company Information Table 106. Elucid Business Overview Table 107. Elucid Cardiac AI-assisted Diagnosis Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Elucid Cardiac AI-assisted Diagnosis Product Portfolio Table 109. Elucid Recent Development Table 110. DiA Imaging Analysis Company Information Table 111. DiA Imaging Analysis Business Overview Table 112. DiA Imaging Analysis Cardiac AI-assisted Diagnosis Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. DiA Imaging Analysis Cardiac AI-assisted Diagnosis Product Portfolio Table 114. DiA Imaging Analysis Recent Development Table 115. Koninklijke Philips N.V Company Information Table 116. Koninklijke Philips N.V Business Overview Table 117. Koninklijke Philips N.V Cardiac AI-assisted Diagnosis Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. Koninklijke Philips N.V Cardiac AI-assisted Diagnosis Product Portfolio Table 119. Koninklijke Philips N.V Recent Development Table 120. Fujifilm Company Information Table 121. Fujifilm Business Overview Table 122. Fujifilm Cardiac AI-assisted Diagnosis Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 123. Fujifilm Cardiac AI-assisted Diagnosis Product Portfolio Table 124. Fujifilm Recent Development Table 125. North America Cardiac AI-assisted Diagnosis Revenue by Type (2021-2026) & (US$ Million) Table 126. North America Cardiac AI-assisted Diagnosis Revenue by Type (2027-2032) & (US$ Million) Table 127. North America Cardiac AI-assisted Diagnosis Revenue by Application (2021-2026) & (US$ Million) Table 128. North America Cardiac AI-assisted Diagnosis Revenue by Application (2027-2032) & (US$ Million) Table 129. North America Cardiac AI-assisted Diagnosis Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 130. North America Cardiac AI-assisted Diagnosis Revenue by Country (2021-2026) & (US$ Million) Table 131. North America Cardiac AI-assisted Diagnosis Revenue by Country (US$ Million) & (2027-2032) Table 132. Europe Cardiac AI-assisted Diagnosis Revenue by Type (2021-2026) & (US$ Million) Table 133. Europe Cardiac AI-assisted Diagnosis Revenue by Type (2027-2032) & (US$ Million) Table 134. Europe Cardiac AI-assisted Diagnosis Revenue by Application (2021-2026) & (US$ Million) Table 135. Europe Cardiac AI-assisted Diagnosis Revenue by Application (2027-2032) & (US$ Million) Table 136. Europe Cardiac AI-assisted Diagnosis Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 137. Europe Cardiac AI-assisted Diagnosis Revenue by Country (2021-2026) & (US$ Million) Table 138. Europe Cardiac AI-assisted Diagnosis Revenue by Country (US$ Million) & (2027-2032) Table 139. China Cardiac AI-assisted Diagnosis Revenue by Type (2021-2026) & (US$ Million) Table 140. China Cardiac AI-assisted Diagnosis Revenue by Type (2027-2032) & (US$ Million) Table 141. China Cardiac AI-assisted Diagnosis Revenue by Application (2021-2026) & (US$ Million) Table 142. China Cardiac AI-assisted Diagnosis Revenue by Application (2027-2032) & (US$ Million) Table 143. Asia Cardiac AI-assisted Diagnosis Revenue by Type (2021-2026) & (US$ Million) Table 144. Asia Cardiac AI-assisted Diagnosis Revenue by Type (2027-2032) & (US$ Million) Table 145. Asia Cardiac AI-assisted Diagnosis Revenue by Application (2021-2026) & (US$ Million) Table 146. Asia Cardiac AI-assisted Diagnosis Revenue by Application (2027-2032) & (US$ Million) Table 147. Asia Cardiac AI-assisted Diagnosis Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 148. Asia Cardiac AI-assisted Diagnosis Revenue by Region (US$ Million) & (2021-2026) Table 149. Asia Cardiac AI-assisted Diagnosis Revenue by Region (US$ Million) & (2027-2032) Table 150. SAMEA Cardiac AI-assisted Diagnosis Revenue by Type (2021-2026) & (US$ Million) Table 151. SAMEA Cardiac AI-assisted Diagnosis Revenue by Type (2027-2032) & (US$ Million) Table 152. SAMEA Cardiac AI-assisted Diagnosis Revenue by Application (2021-2026) & (US$ Million) Table 153. SAMEA Cardiac AI-assisted Diagnosis Revenue by Application (2027-2032) & (US$ Million) Table 154. SAMEA Cardiac AI-assisted Diagnosis Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 155. SAMEA Cardiac AI-assisted Diagnosis Revenue by Country (2021-2026) & (US$ Million) Table 156. SAMEA Cardiac AI-assisted Diagnosis Revenue by Country (US$ Million) & (2027-2032) Table 157. Research Programs/Design for This Report Table 158. Authors List of This Report Table 159. Secondary Sources Table 160. Primary Sources List of Figures Figure 1. Cardiac AI-assisted Diagnosis Image Figure 2. Global Cardiac AI-assisted Diagnosis Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cardiac AI-assisted Diagnosis Market Size Share 2021 VS 2025 VS 2032 Figure 4. Cloud-based Image Figure 5. On-Primes Image Figure 6. Global Cardiac AI-assisted Diagnosis Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Cardiac AI-assisted Diagnosis Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Imaging Center Image Figure 11. Global Cardiac AI-assisted Diagnosis Market Size (US$ Million) & (2021-2032) Figure 12. Global Cardiac AI-assisted Diagnosis Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Cardiac AI-assisted Diagnosis Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Cardiac AI-assisted Diagnosis Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Cardiac AI-assisted Diagnosis Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Cardiac AI-assisted Diagnosis Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Cardiac AI-assisted Diagnosis Revenue Market Share by Type (2021-2032) Figure 19. Global Cardiac AI-assisted Diagnosis Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Cardiac AI-assisted Diagnosis Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Cardiac AI-assisted Diagnosis Revenue Market Share by Application (2021-2032) Figure 22. North America Cardiac AI-assisted Diagnosis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Cardiac AI-assisted Diagnosis Revenue Share by Type (2021-2032) Figure 24. North America Cardiac AI-assisted Diagnosis Revenue Share by Application (2021-2032) Figure 25. North America Cardiac AI-assisted Diagnosis Revenue Share by Country (2021-2032) Figure 26. United States Cardiac AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Cardiac AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Cardiac AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Cardiac AI-assisted Diagnosis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Cardiac AI-assisted Diagnosis Revenue Share by Type (2021-2032) Figure 31. Europe Cardiac AI-assisted Diagnosis Revenue Share by Application (2021-2032) Figure 32. Europe Cardiac AI-assisted Diagnosis Revenue Share by Country (2021-2032) Figure 33. Germany Cardiac AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Cardiac AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Cardiac AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Cardiac AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Cardiac AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Cardiac AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Cardiac AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Cardiac AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Cardiac AI-assisted Diagnosis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Cardiac AI-assisted Diagnosis Revenue Share by Type (2021-2032) Figure 43. China Cardiac AI-assisted Diagnosis Revenue Share by Application (2021-2032) Figure 44. Asia Cardiac AI-assisted Diagnosis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Cardiac AI-assisted Diagnosis Revenue Share by Type (2021-2032) Figure 46. Asia Cardiac AI-assisted Diagnosis Revenue Share by Application (2021-2032) Figure 47. Asia Cardiac AI-assisted Diagnosis Revenue Share by Region (2021-2032) Figure 48. Japan Cardiac AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Cardiac AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Cardiac AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Cardiac AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Cardiac AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Cardiac AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Cardiac AI-assisted Diagnosis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Cardiac AI-assisted Diagnosis Revenue Share by Type (2021-2032) Figure 56. SAMEA Cardiac AI-assisted Diagnosis Revenue Share by Application (2021-2032) Figure 57. SAMEA Cardiac AI-assisted Diagnosis Revenue Share by Country (2021-2032) Figure 58. Brazil Cardiac AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Cardiac AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Cardiac AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Cardiac AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Cardiac AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Cardiac AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Cardiac AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Cardiac AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Cardiac AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Cardiac AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Cardiac AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Cloud-based
  • On-Primes
Applications
  • Hospital
  • Clinic
  • Imaging Center
Companies covered
  • Lepu Medical
  • G K Healthcare
  • Sense Time
  • United Imaging
  • Infervision
  • Shukun
  • FOSUN AITROX
  • NANO-X
  • MyCardium AI
  • VUNO
  • Caption Care
  • UltraSight
  • Ultromics
  • Cleerly
  • Elucid
  • DiA Imaging Analysis
  • Koninklijke Philips N.V
  • Fujifilm

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Cardiac AI-assisted Diagnosis Market by Type
  3. 1.2.1 Global Cardiac AI-assisted Diagnosis Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Cloud-based
  5. 1.2.3 On-Primes
  6. 1.3 Cardiac AI-assisted Diagnosis Market by Application
  7. 1.3.1 Global Cardiac AI-assisted Diagnosis Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.3.4 Imaging Center
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Cardiac AI-assisted Diagnosis Market Dynamics
  1. 2.1 Cardiac AI-assisted Diagnosis Industry Trends
  2. 2.2 Cardiac AI-assisted Diagnosis Industry Drivers
  3. 2.3 Cardiac AI-assisted Diagnosis Industry Opportunities and Challenges
  4. 2.4 Cardiac AI-assisted Diagnosis Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Cardiac AI-assisted Diagnosis Market Perspective (2021-2032)
  2. 3.2 Global Cardiac AI-assisted Diagnosis Growth Trends by Region
  3. 3.2.1 Global Cardiac AI-assisted Diagnosis Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Cardiac AI-assisted Diagnosis Market Size by Region (2021-2026)
  5. 3.2.3 Global Cardiac AI-assisted Diagnosis Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Cardiac AI-assisted Diagnosis Revenue by Players
  2. 4.1.1 Global Cardiac AI-assisted Diagnosis Revenue by Players (2021-2026)
  3. 4.1.2 Global Cardiac AI-assisted Diagnosis Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Cardiac AI-assisted Diagnosis Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Cardiac AI-assisted Diagnosis Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Cardiac AI-assisted Diagnosis Key Players Headquarters & Area Served
  7. 4.4 Global Cardiac AI-assisted Diagnosis Players, Product Type & Application
  8. 4.5 Global Cardiac AI-assisted Diagnosis Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Cardiac AI-assisted Diagnosis Market CR5 and HHI
  11. 4.6.3 2025 Cardiac AI-assisted Diagnosis Tier 1, Tier 2, and Tier 3
5 Cardiac AI-assisted Diagnosis Market Size by Type
  1. 5.1 Global Cardiac AI-assisted Diagnosis Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Cardiac AI-assisted Diagnosis Revenue by Type (2021-2032)
  3. 5.3 Global Cardiac AI-assisted Diagnosis Revenue Market Share by Type (2021-2032)
6 Cardiac AI-assisted Diagnosis Market Size by Application
  1. 6.1 Global Cardiac AI-assisted Diagnosis Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Cardiac AI-assisted Diagnosis Revenue by Application (2021-2032)
  3. 6.3 Global Cardiac AI-assisted Diagnosis Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Lepu Medical
  2. 7.1.1 Lepu Medical Company Information
  3. 7.1.2 Lepu Medical Business Overview
  4. 7.1.3 Lepu Medical Cardiac AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Lepu Medical Cardiac AI-assisted Diagnosis Product Portfolio
  6. 7.1.5 Lepu Medical Recent Developments
  7. 7.2 G K Healthcare
  8. 7.2.1 G K Healthcare Company Information
  9. 7.2.2 G K Healthcare Business Overview
  10. 7.2.3 G K Healthcare Cardiac AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  11. 7.2.4 G K Healthcare Cardiac AI-assisted Diagnosis Product Portfolio
  12. 7.2.5 G K Healthcare Recent Developments
  13. 7.3 Sense Time
  14. 7.3.1 Sense Time Company Information
  15. 7.3.2 Sense Time Business Overview
  16. 7.3.3 Sense Time Cardiac AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Sense Time Cardiac AI-assisted Diagnosis Product Portfolio
  18. 7.3.5 Sense Time Recent Developments
  19. 7.4 United Imaging
  20. 7.4.1 United Imaging Company Information
  21. 7.4.2 United Imaging Business Overview
  22. 7.4.3 United Imaging Cardiac AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  23. 7.4.4 United Imaging Cardiac AI-assisted Diagnosis Product Portfolio
  24. 7.4.5 United Imaging Recent Developments
  25. 7.5 Infervision
  26. 7.5.1 Infervision Company Information
  27. 7.5.2 Infervision Business Overview
  28. 7.5.3 Infervision Cardiac AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Infervision Cardiac AI-assisted Diagnosis Product Portfolio
  30. 7.5.5 Infervision Recent Developments
  31. 7.6 Shukun
  32. 7.6.1 Shukun Company Information
  33. 7.6.2 Shukun Business Overview
  34. 7.6.3 Shukun Cardiac AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Shukun Cardiac AI-assisted Diagnosis Product Portfolio
  36. 7.6.5 Shukun Recent Developments
  37. 7.7 FOSUN AITROX
  38. 7.7.1 FOSUN AITROX Company Information
  39. 7.7.2 FOSUN AITROX Business Overview
  40. 7.7.3 FOSUN AITROX Cardiac AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  41. 7.7.4 FOSUN AITROX Cardiac AI-assisted Diagnosis Product Portfolio
  42. 7.7.5 FOSUN AITROX Recent Developments
  43. 7.8 NANO-X
  44. 7.8.1 NANO-X Company Information
  45. 7.8.2 NANO-X Business Overview
  46. 7.8.3 NANO-X Cardiac AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  47. 7.8.4 NANO-X Cardiac AI-assisted Diagnosis Product Portfolio
  48. 7.8.5 NANO-X Recent Developments
  49. 7.9 MyCardium AI
  50. 7.9.1 MyCardium AI Company Information
  51. 7.9.2 MyCardium AI Business Overview
  52. 7.9.3 MyCardium AI Cardiac AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  53. 7.9.4 MyCardium AI Cardiac AI-assisted Diagnosis Product Portfolio
  54. 7.9.5 MyCardium AI Recent Developments
  55. 7.10 VUNO
  56. 7.10.1 VUNO Company Information
  57. 7.10.2 VUNO Business Overview
  58. 7.10.3 VUNO Cardiac AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  59. 7.10.4 VUNO Cardiac AI-assisted Diagnosis Product Portfolio
  60. 7.10.5 VUNO Recent Developments
  61. 7.11 Caption Care
  62. 7.11.1 Caption Care Company Information
  63. 7.11.2 Caption Care Business Overview
  64. 7.11.3 Caption Care Cardiac AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Caption Care Cardiac AI-assisted Diagnosis Product Portfolio
  66. 7.11.5 Caption Care Recent Developments
  67. 7.12 UltraSight
  68. 7.12.1 UltraSight Company Information
  69. 7.12.2 UltraSight Business Overview
  70. 7.12.3 UltraSight Cardiac AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  71. 7.12.4 UltraSight Cardiac AI-assisted Diagnosis Product Portfolio
  72. 7.12.5 UltraSight Recent Developments
  73. 7.13 Ultromics
  74. 7.13.1 Ultromics Company Information
  75. 7.13.2 Ultromics Business Overview
  76. 7.13.3 Ultromics Cardiac AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Ultromics Cardiac AI-assisted Diagnosis Product Portfolio
  78. 7.13.5 Ultromics Recent Developments
  79. 7.14 Cleerly
  80. 7.14.1 Cleerly Company Information
  81. 7.14.2 Cleerly Business Overview
  82. 7.14.3 Cleerly Cardiac AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Cleerly Cardiac AI-assisted Diagnosis Product Portfolio
  84. 7.14.5 Cleerly Recent Developments
  85. 7.15 Elucid
  86. 7.15.1 Elucid Company Information
  87. 7.15.2 Elucid Business Overview
  88. 7.15.3 Elucid Cardiac AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Elucid Cardiac AI-assisted Diagnosis Product Portfolio
  90. 7.15.5 Elucid Recent Developments
  91. 7.16 DiA Imaging Analysis
  92. 7.16.1 DiA Imaging Analysis Company Information
  93. 7.16.2 DiA Imaging Analysis Business Overview
  94. 7.16.3 DiA Imaging Analysis Cardiac AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  95. 7.16.4 DiA Imaging Analysis Cardiac AI-assisted Diagnosis Product Portfolio
  96. 7.16.5 DiA Imaging Analysis Recent Developments
  97. 7.17 Koninklijke Philips N.V
  98. 7.17.1 Koninklijke Philips N.V Company Information
  99. 7.17.2 Koninklijke Philips N.V Business Overview
  100. 7.17.3 Koninklijke Philips N.V Cardiac AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Koninklijke Philips N.V Cardiac AI-assisted Diagnosis Product Portfolio
  102. 7.17.5 Koninklijke Philips N.V Recent Developments
  103. 7.18 Fujifilm
  104. 7.18.1 Fujifilm Company Information
  105. 7.18.2 Fujifilm Business Overview
  106. 7.18.3 Fujifilm Cardiac AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Fujifilm Cardiac AI-assisted Diagnosis Product Portfolio
  108. 7.18.5 Fujifilm Recent Developments
8 North America
  1. 8.1 North America Cardiac AI-assisted Diagnosis Revenue (2021-2032)
  2. 8.2 North America Cardiac AI-assisted Diagnosis Revenue by Type (2021-2032)
  3. 8.2.1 North America Cardiac AI-assisted Diagnosis Revenue by Type (2021-2026)
  4. 8.2.2 North America Cardiac AI-assisted Diagnosis Revenue by Type (2027-2032)
  5. 8.3 North America Cardiac AI-assisted Diagnosis Revenue Share by Type (2021-2032)
  6. 8.4 North America Cardiac AI-assisted Diagnosis Revenue by Application (2021-2032)
  7. 8.4.1 North America Cardiac AI-assisted Diagnosis Revenue by Application (2021-2026)
  8. 8.4.2 North America Cardiac AI-assisted Diagnosis Revenue by Application (2027-2032)
  9. 8.5 North America Cardiac AI-assisted Diagnosis Revenue Share by Application (2021-2032)
  10. 8.6 North America Cardiac AI-assisted Diagnosis Revenue by Country
  11. 8.6.1 North America Cardiac AI-assisted Diagnosis Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Cardiac AI-assisted Diagnosis Revenue by Country (2021-2026)
  13. 8.6.3 North America Cardiac AI-assisted Diagnosis Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Cardiac AI-assisted Diagnosis Revenue (2021-2032)
  2. 9.2 Europe Cardiac AI-assisted Diagnosis Revenue by Type (2021-2032)
  3. 9.2.1 Europe Cardiac AI-assisted Diagnosis Revenue by Type (2021-2026)
  4. 9.2.2 Europe Cardiac AI-assisted Diagnosis Revenue by Type (2027-2032)
  5. 9.3 Europe Cardiac AI-assisted Diagnosis Revenue Share by Type (2021-2032)
  6. 9.4 Europe Cardiac AI-assisted Diagnosis Revenue by Application (2021-2032)
  7. 9.4.1 Europe Cardiac AI-assisted Diagnosis Revenue by Application (2021-2026)
  8. 9.4.2 Europe Cardiac AI-assisted Diagnosis Revenue by Application (2027-2032)
  9. 9.5 Europe Cardiac AI-assisted Diagnosis Revenue Share by Application (2021-2032)
  10. 9.6 Europe Cardiac AI-assisted Diagnosis Revenue by Country
  11. 9.6.1 Europe Cardiac AI-assisted Diagnosis Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Cardiac AI-assisted Diagnosis Revenue by Country (2021-2026)
  13. 9.6.3 Europe Cardiac AI-assisted Diagnosis Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Cardiac AI-assisted Diagnosis Revenue (2021-2032)
  2. 10.2 China Cardiac AI-assisted Diagnosis Revenue by Type (2021-2032)
  3. 10.2.1 China Cardiac AI-assisted Diagnosis Revenue by Type (2021-2026)
  4. 10.2.2 China Cardiac AI-assisted Diagnosis Revenue by Type (2027-2032)
  5. 10.3 China Cardiac AI-assisted Diagnosis Revenue Share by Type (2021-2032)
  6. 10.4 China Cardiac AI-assisted Diagnosis Revenue by Application (2021-2032)
  7. 10.4.1 China Cardiac AI-assisted Diagnosis Revenue by Application (2021-2026)
  8. 10.4.2 China Cardiac AI-assisted Diagnosis Revenue by Application (2027-2032)
  9. 10.5 China Cardiac AI-assisted Diagnosis Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Cardiac AI-assisted Diagnosis Revenue (2021-2032)
  2. 11.2 Asia Cardiac AI-assisted Diagnosis Revenue by Type (2021-2032)
  3. 11.2.1 Asia Cardiac AI-assisted Diagnosis Revenue by Type (2021-2026)
  4. 11.2.2 Asia Cardiac AI-assisted Diagnosis Revenue by Type (2027-2032)
  5. 11.3 Asia Cardiac AI-assisted Diagnosis Revenue Share by Type (2021-2032)
  6. 11.4 Asia Cardiac AI-assisted Diagnosis Revenue by Application (2021-2032)
  7. 11.4.1 Asia Cardiac AI-assisted Diagnosis Revenue by Application (2021-2026)
  8. 11.4.2 Asia Cardiac AI-assisted Diagnosis Revenue by Application (2027-2032)
  9. 11.5 Asia Cardiac AI-assisted Diagnosis Revenue Share by Application (2021-2032)
  10. 11.6 Asia Cardiac AI-assisted Diagnosis Revenue by Country
  11. 11.6.1 Asia Cardiac AI-assisted Diagnosis Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Cardiac AI-assisted Diagnosis Revenue by Country (2021-2026)
  13. 11.6.3 Asia Cardiac AI-assisted Diagnosis Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Cardiac AI-assisted Diagnosis Revenue (2021-2032)
  2. 12.2 SAMEA Cardiac AI-assisted Diagnosis Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Cardiac AI-assisted Diagnosis Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Cardiac AI-assisted Diagnosis Revenue by Type (2027-2032)
  5. 12.3 SAMEA Cardiac AI-assisted Diagnosis Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Cardiac AI-assisted Diagnosis Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Cardiac AI-assisted Diagnosis Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Cardiac AI-assisted Diagnosis Revenue by Application (2027-2032)
  9. 12.5 SAMEA Cardiac AI-assisted Diagnosis Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Cardiac AI-assisted Diagnosis Revenue by Country
  11. 12.6.1 SAMEA Cardiac AI-assisted Diagnosis Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Cardiac AI-assisted Diagnosis Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Cardiac AI-assisted Diagnosis Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst